ŠÁLEK, Cyril. Zpráva o průběhu KH Blina-CELL 1.6.2022 — 31.5.2023 (Progress Report of KH Blina-CELL 1.6.2022 — 31.5.2023). NA. Praha: ÚHKT PRAHA, 2023, 4 pp. NA.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Zpráva o průběhu KH Blina-CELL 1.6.2022 — 31.5.2023
Name in Czech Zpráva o průběhu KH Blina-CELL 1.6.2022 — 31.5.2023
Authors ŠÁLEK, Cyril.
Edition NA. Praha, 4 pp. NA, 2023.
Publisher ÚHKT PRAHA
Other information
Original language English
Type of outcome Research report
Field of Study 30230 Other clinical medicine subjects
Country of publisher Czech Republic
Confidentiality degree is not subject to a state or trade secret
WWW BLINA-CELL
Organization unit Faculty of Medicine
Keywords (in Czech) blinatumomab; high-dose chemotherapy; acute lymphoblastic leukemia
Keywords in English blinatumomab; high-dose chemotherapy; acute lymphoblastic leukemia
Tags interim report, UHKT, user
Tags International impact
Changed by Changed by: Bc. Hana Vladíková, BBA, učo 244692. Changed: 16/1/2024 10:17.
Abstract
Eudra CT 2017-004577-14, Blina-Cell, NCT04554485: Single cycle of blinatumomab followed by high-dose chemotherapy in the induction therapy for Ph-negative acute lymphoblastic leukemia in adults. (Principal Investigator: doc. MUDr. Mgr. Cyril Šálek, Ph.D., cyril.salek@uhkt.cz). Single cycle of blinatumomab followed by high-dose chemotherapy in the induction therapy for Ph-negative acute lymphoblastic leukemia in adults.
Links
90249, large research infrastructuresName: CZECRIN IV
PrintDisplayed: 17/5/2024 18:04